GSK has outperformed both the healthcare sector and S&P 500 this year, which is notable considering the spectre of high ...

GSK has struck a voluntary agreement with the US government to lower the cost of prescription medicines, and expand access to ...

What is Exdensur? A new FDA-approved asthma biologic from GSK that only needs two doses a year for severe eosinophilic asthma ...

An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK plc has continued its share buyback programme, repurchasing 232,912 ...

SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics (207940.KS) said on Monday it is acquiring its first U.S. drug ...

Investing.com -- GSK plc (LON:GSK) has entered into an agreement with the U.S. government to reduce prescription medicine costs for American patients, particularly for its respiratory portfolio that ...

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making ...

GSK is embarking on a journey with CAMP4 Therapeutics, paying $17.5 million upfront to collaborate on regulatory RNA-targeting therapeutics in neurodegenerative and kidney disease indications.

Samsung Biologics has agreed to acquire GlaxoSmithKline’s Human Genome Sciences and its two pharmaceutical manufacturing ...

CAMP4 signs ASO collaboration with GSK, securing $17.5 million upfront as analysts reaffirm Outperform and highlight 2026 ...

GSK PLC GSK shares shed 1.15% to £18.13 Thursday, on what proved to be an all-around positive trading session for the stock ...

Drugmaker GSK has struck an agreement with the US to cut the cost of prescription medicines for American patients, including ...